Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.

@article{Bissonnette2010EfficacyAS,
  title={Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial.},
  author={Robert Bissonnette and Genhui Chen and Chantal Bolduc and Catherine Maari and Michael Lyle and Liren Tang and John Webster and Youwen Zhou},
  journal={Archives of dermatology},
  year={2010},
  volume={146 4},
  pages={
          446-9
        }
}
explain unique variance associated with sunbathing intentions and intentions to sun protect. For both analyses, age, sex, skin type, and perceived susceptibility were entered in step 1, followed by the 3 appearance-based tanning motives (appearance reasons to tan, appearance reasons not to tan, and sociocultural influences) entered in step 2. The overall R for both analyses was significant and indicated that a high level of variance was accounted for by the predictors (sunbathing R=.50; sun… 
View on PubMed
jamanetwork.com
34 Citations
Highly Influential Citations
3
Background Citations
12

Figures from this paper

34 Citations

New therapies for atopic dermatitis: Additional treatment classes
TREATMENT CHALLENGES IN ATOPIC DERMATITIS WITH NOVEL TOPICAL THERAPIES
TLDR
The majority of emerging therapies for AD are focused on inhibiting phosphodiesterase 4 (PDE4), an enzyme which is increased in inflammatory disorders such as AD.
Topical agents for the treatment of atopic dermatitis
TLDR
A comprehensive overview of new and upcoming topical therapies currently in development and undergoing clinical trials, as well as their safety and efficacy profiles, are provided, and current topicals used in the management of AD are discussed.
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies
TLDR
Novel topical therapies are in the pipeline and comprise both new doses and formulations of well-known pharmaceutical molecules and novel approaches targeting unique inflammatory pathways and mechanisms of disease, with a promise of higher efficacy and less harmful side effects.
Novel investigational therapies for atopic dermatitis
TLDR
In alignment with the recent drug development of other dermatological diseases, antibodies directed at key molecules in the pathogenesis of AD appear to be the most promising.
The role of interleukin-24 in atopic dermatitis
TLDR
It is suggested that co-treatment of tapinarof with therapeutics that block IL-24 signaling may represent a promising strategy for managing AD.
Systemic Pharmacokinetics, Safety, and Preliminary Efficacy of Topical AhR Agonist Tapinarof: Results of a Phase 1 Study
TLDR
The 1% cream was selected as the concentration for use in future studies because of its lower AE incidence and efficacy comparable to the 2% cream, and the efficacy and safety of 1% tapinarof support results of previous positive studies that used a different formulation.
New and Emerging Therapies for Pediatric Atopic Dermatitis
TLDR
New and emerging AD therapies will be discussed along with their mechanisms of action and their potential based on clinical study data.
Future treatment options for atopic dermatitis - small molecules and beyond.
Adult atopic dermatitis: new and emerging therapies
TLDR
Clinical trials showed that JAK inhibitors, PDE-4 inhibitors and monoclonal antibodies against some IL seem to be the most promising drugs, but dermatologists will have to evaluate their effectiveness and safety in clinical practice.
...
...

References

SHOWING 1-10 OF 15 REFERENCES
An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing Surveillance
TLDR
There is no clinical evidence to establish that treatment with pimecrolimus cream 1% increases the risk of malignancy, and these data demonstrate that topically applied pimeCrolimus is minimally absorbed through the skin and has afavourable safety margin.
Appearance Motives to Tan and Not Tan: Evidence for Validity and Reliability of a New Scale
TLDR
This study offers a framework and measurement instrument that has evidence of validity and reliability for evaluating appearance-based motives to tan and not tan and evaluates internal consistency, temporal stability, and criterion-related validity.
Investigating the role of appearance-based factors in predicting sunbathing and tanning salon use
TLDR
Examination of models that prospectively predict sunbathing and indoor tanning behaviors using constructs and interrelationships derived from the tripartite theory of body image, theory of reasoned action, health belief model, revised protection motivation theory, and a proposed integration of several health behavior models generally support a model in which intentions mediate the role of perceived threat on behaviors.
Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis.
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis
TLDR
Overall intra‐evaluator reliability of the EASI was in the fair‐to‐good range and there was consistency among the evaluators between consecutive days of evaluation, which support the use of theEASI in clinical trials of therapeutic agents for AD.
Topical immunomodulators for atopic dermatitis
TLDR
Atopic dermatitis is the most common chronic skin disease in childhood, with a prevalence of 7 to 12% in school-age children, and much effort has recently been placed on the development of new treatment strategies.
A systematic review of the safety of topical therapies for atopic dermatitis
TLDR
The safety of topical therapies for atopic dermatitis, a common and morbid disease, has recently been the focus of increased scrutiny, adding confusion as how to manage patients.
Exercise-induced urticarial vasculitis as a paraneoplastic manifestation of cystic teratoma.
TLDR
This is the first report of UV as a paraneoplastic manifestation which is triggered by exercise, and a patient who developed UV after exercise, who was incidentally diagnosed as having a cystic teratoma, and who did not suffer from the exercise-induced UV after the tumour had been surgically resected.
Relapsing leukocytoclastic vasculitis triggered by activity in a young woman.
TLDR
Assessment in vivo of African American hair was difficult owing to hair curling and background skin pigmentation, but trichoscopy was extremely useful on cut hair samples.
Severity Scoring of Atopic Dermatitis: The SCORAD Index
TLDR
Assessment methods for atopic dermatitis are not standardized, and therapeutic studies are difficult to interpret, so consensus on these methods is needed to obtain a consensus on them.
...
...